Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Condition:   Relapsed or Refractory Peripheral T-cell Lymphoma Intervention:   Drug: Chidamide Sponsor:   Great Novel Therapeutics Biotech& Medicals Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials